Remimazolam compared with propofol for blood pressure stability during aortic aneurysm repair
Compares remimazolam and propofol anesthesia for blood pressure support needs in aortic aneurysm repair.
Key facts
- Who runs it
- Seoul National University Hospital
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- Effect of Remimazolam Versus Propofol Total Intravenous Anesthesia on Intraoperative Hemodynamic Stability in Patients Undergoing Thoracic or Abdominal Endovascular Aortic Repair
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 44 people, planned
- Started
- 1 Oct 2026
- Expected to end
- 30 Oct 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Remimazolam Besylate
- propofol
- Record updated
- 29 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a thoracic or abdominal aortic aneurysm who are scheduled for endovascular aortic repair (TEVAR/EVAR) under general anesthesia. It compares two anesthesia drugs, remimazolam and propofol, and how well they keep blood pressure steady.
- Age
- 20 years or older
- Sex
- All sexes can join
- Disease stage
- Thoracic or abdominal aortic aneurysm with a planned, non-emergency endovascular aortic repair (TEVAR/EVAR) under general anesthesia
- Earlier treatment
- People who take opioids or benzodiazepines over a long time cannot join.
Main reasons for not taking part
- Allergy or hypersensitivity to the study drugs, known or suspected
- ASA physical status class IV or higher, or an emergency procedure
- Body mass index (BMI) ≥ 30 kg/m^2
- Severe heart weakness (left ventricular ejection fraction < 40%), severe liver disease (Child-Pugh class C), albumin < 2.0 g/dL, or kidney failure needing dialysis
- Alcohol or drug abuse, memory or thinking problems before surgery, pregnancy or breastfeeding
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Adults aged 20 years or older scheduled for thoracic or abdominal endovascular aortic repair (TEVAR/EVAR) under general anesthesia for thoracic or abdominal aortic aneurysm
Who cannot take part
- Known or suspected allergy or hypersensitivity to the study drugs
- History of alcohol or drug abuse
- Preoperative cognitive impairment
- Acute or chronic renal failure requiring dialysis
- Severe left ventricular dysfunction (left ventricular ejection fraction < 40%)
- Severe hypoalbuminemia (< 2.0 g/dL)
- ASA physical status class IV or higher
- Body mass index (BMI) ≥ 30 kg/m\^2
- Chronic use of opioids or benzodiazepines
- Severe hepatic dysfunction (Child-Pugh class C)
- Pregnancy or breastfeeding
- Emergency procedure
Where in South Korea
- Seoul National University HospitalSeoul, South KoreaContact: Youn Joung Cho, MD, PhDTaking people
About the trial
What the trial wants to find out
The purpose of this study is to compare two intravenous anesthetics, remimazolam and propofol, for their effects on intraoperative hemodynamic stability in patients undergoing thoracic or abdominal endovascular aortic repair. Maintaining blood pressure during these procedures is important to preserve organ perfusion, yet anesthetic-induced hypotension often requires vasopressor support. Since direct comparisons of these two anesthetics on hemodynamic outcomes in this population are limited, this randomized, single-blind, controlled trial will compare the intraoperative vasopressor requirement between the two groups to provide evidence for selecting a more hemodynamically stable anesthetic in these high-risk patients.
The 2 groups in the trial
- Remimazolam groupTreatment being tested
Remimazolam Besylate (2mg/mL)
Treatment: Remimazolam Besylate
- Propofol groupTreatment being tested
Propofol (20mg/mL)
Treatment: propofol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Remimazolam Versus Propofol Total Intravenous Anesthesia on Intraoperative Hemodynamic Stability in Patients Undergoing Thoracic or Abdominal Endovascular Aortic Repair: A Randomized, Single-blind, Controlled Clinical Trial
- Plain-language title
- Remimazolam compared with propofol for blood pressure stability during aortic aneurysm repairGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 29 October 2026